单分子荧光共振能量转移技术在核糖体移位研究中的进展

核糖体是蛋白质的"合成工厂",也是临床上多种抗菌药物的作用靶点,因此,深入理解细菌核糖体的蛋白质翻译机制意义重大.蛋白质翻译是通过多步骤相互协调、多组分精细配合来实现高保真和精确调控.核糖体在mRNA上的移位作为翻译过程中最重要的事件之一,需要核糖体大规模的构象重排以及tRNA2-mRNA沿着核糖体的精确移动.在细菌中,移位是由延伸因子EF-G催化GTP水解来驱动的.近年来,单分子荧光共振能量技术(smFRET)的发展使得人们可以探究单个tRNA分子移位的动力学过程并实时观测核糖体的构象变化.本文首先介绍了smFRET技术的原理及特点,对其在核糖体结构动态及tRNA移位研究中的应用进行了较为系统的总结,并对其应用前景进行了展望.     

表观遗传和蛋白质翻译后修饰在细菌耐药中的作用

日益严重的细菌耐药性有可能使人类重回前抗生素时代。细菌的耐药机理多样,深入研究细菌的耐药性形成机理有助于开发控制耐药细菌感染的新措施。表观遗传和蛋白质翻译后修饰在细胞代谢、信号转导、蛋白质降解、调控DNA复制、应激反应等方面都具有重要作用。近年来研究表明表观遗传和蛋白质翻译后修饰在细菌耐药中也扮演着重要的角色。本文总结了DNA甲基化、调控型RNAs等表观遗传因素和磷酸化、琥珀酰基化等蛋白质翻译后修饰因素在细菌耐药性中的调控作用,以期为抗生素靶标选择和抗生素开发设计提供新思路。     

反式翻译模型

反式翻译是细菌体内一种修复翻译水平上受阻的遗传信息表达过程的机制。tmRNA是反式翻译的核心分子,它兼具tRNA和mRNA的特点,在SmpB蛋白的帮助下特异性识别携带mRNA缺失体的核糖体,在核糖体蛋白S1的传递作用下结合在A位点上,一方面延续被中断的mRNA上的遗传信息,一方面终止蛋白质的合成,释放被束缚的核糖体和tRNA进入新的翻译过程。本文对近年来关于反式翻译模型的研究进行综述。     

“严谨反应”还是“严紧反应”?

“Stringent response”是指细菌在遭受营养饥饿与环境胁迫时,由代谢酶RelA/SpoT催化合成信号分子鸟苷四/五磷酸[(p)ppGpp],从而诱导细菌细胞关闭rRNA、tRNA及核糖体蛋白基因转录,停止多种蛋白质的翻译,严控大部分代谢活动的一系列适应性基因表达过程。“Stringent response”几乎是所有细菌应对逆境的重要调节机制。目前,国内文献对“stringent response”的中文翻译存在“严谨反应”和“严紧反应”混用的现象。基于此,本文对“stringent response”的调控机制、生理功能及字面含义进行了分析,认为“stringent response”翻译为“严紧反应”更为合理、准确。     

细菌反式翻译系统

反式翻译（trans?translation）是细菌翻译质量控制的关键,几乎存在于所有细菌之中。反式翻译系统由转移信使mRNA（tmRNA）和小蛋白B（SmpB）组成,能够拯救因翻译不终止mRNA (non?stop mRNA)而滞留的核糖体。此外,反式翻译还能够调控特定基因的表达水平,参与细菌的应激反应。概括了细菌反式翻译系统近年来最新的研究进展,阐明反式翻译识别与拯救滞留核糖体的分子机制,归纳了反式翻译的功能及应用前景,以期为相关研究提供参考。     

细菌对氨基糖苷类抗生素的耐药机制

氨基糖苷类抗生素起源于1944年链霉素的发现,其主要抑制细菌蛋白质的合成,以及破坏细菌胞浆膜的完整性。具有抗菌谱广、杀菌完全、与β-内酰胺等抗生素有很好的协同作用,是最常用的抗感染药物。它依赖电子转运,通过细菌内膜而到达胞质溶胶中后,与核糖体30S亚基结合,但这种结合并不阻止起始复合物的形成,而是通过破坏控制翻译准确性的校读过程来干扰新生链的延长。随着临床的广泛和不科学使用,细菌对氨基糖苷类抗生素的耐药性逐年增高,其耐药机制也十分复杂,主要包括细菌产生使抗生素失活的修饰酶、细菌对药物的摄取和积累减少,以及核糖体结合位点的减少等;另外还发现有新的机制参与细菌对氨基糖苷类抗生素的耐药过程。现将细菌对氨基糖苷类抗生素的耐药机制进行综述,并探讨联合用药控制耐药。     

蛋白质翻译中的反转运

在蛋白质的翻译过程中,氨酰-tRNA进入核糖体,解密mRNA上的一个密码子,并带着mRNA向其5'的方向运动,直到空载的tRNA离开核糖体,整个过程tRNA在核糖体内始终沿着一个方向运动.但随着LepA(EF4)蛋白的发现和其功能的明确,tRNA在核糖体内的新运动形式--"反转运"被揭示,即tRNA带着mRNA倒退一步,向其3'的方向运动.通过对tRNA反向运动生理意义的研究,引发了对蛋白质翻译调控的深入思考.     

线粒体核糖体——细胞器中的翻译机器

线粒体核糖体作为细胞器中的翻译机器,与细菌核糖体以及真核细胞质核糖体在rRNA和蛋白质组分、拓扑结构、来源等方面差异显著。本文综述线粒体核糖体研究进展,对比分析其理化性质和实验结构的相似性与特殊性。基于线粒体核糖体的结构和生物学功能进一步推测:经过与tRNA的相互识别和空间取向,mRNA链构象能否影响其编码产物——新生肽链的构象,期望揭示mRNA在翻译过程中可能的作用机理。     

sRNA调控细菌耐药相关基因表达研究进展

近年来随着抗菌药物的广泛应用,造成各种耐药菌、多重耐药菌甚至是超级细菌的出现,对抗菌治疗产生严重的威胁。sRNA是一类新发现的基因表达调控因子,通过与靶mRNA或靶蛋白配对,从而调控细胞的生理功能以应对各种环境变化。研究表明,sRNA能够在细菌耐药过程中(如阻碍抗生素进入细胞、将药物外排出菌胞)发挥重要的调控作用。就sRNA参与调控细菌耐药机制相关基因的表达研究展开系统综述,从而为阐明耐药机制及发现新的药物靶点提供有益参考。     

真核翻译起始因子5A在蛋白质合成中的功能及机制

在蛋白质合成过程中,除核糖体、氨酰 tRNA和mRNA外,还有多种翻译因子参与其中。真核翻译起始因子5A（eukaryotic translation initiation factor 5A, eIF5A）是维持细胞活性必不可少的翻译因子,在进化上高度保守。eIF5A是真核细胞中唯一含有羟腐胺赖氨酸（hypusine）的蛋白质,该翻译后修饰对eIF5A的活性至关重要。1978年,人们首次鉴定出eIF5A,认为它在翻译起始阶段促进第1个肽键的形成。直到2013年才证实它主要在翻译延伸阶段调控含多聚脯氨酸基序蛋白质的翻译。在经过四十多年研究后,人们对eIF5A的功能有了新的认识。近期基于核糖体图谱数据的分析表明,eIF5A能够缓解翻译延伸过程中核糖体在多种基序处的停滞,并不局限于多聚脯氨酸基序,并且它还能够通过促进肽链的释放增强翻译终止。此外,eIF5A还可以通过调控某些蛋白质的翻译,间接影响细胞内的各种生命活动。本文综述了eIF5A的多种翻译后修饰、在蛋白质合成和细胞自噬过程中的调控作用以及与人类疾病的关系,并与细菌及古细菌中的同源蛋白质进行了比较,探讨了该因子在进化中的保守性,以期为相关领域的研究提供一定的理论基础。     

胱氨酸/半胱氨酸调控活性氧代谢影响大肠杆菌耐药性

【背景】随着越来越多超级细菌出现和抗生素资源的渐渐枯竭,细菌耐药机制研究愈加重要。【目的】探讨大肠杆菌内源半胱氨酸推动Fenton反应,调控胞内的活性氧水平,从而影响细菌耐药性这一代谢途径。【方法】在贫硫的培养条件下,通过控制外源胱氨酸和抗生素浓度,研究了胱氨酸/半胱氨酸对大肠杆菌耐药性的影响。【结果】较低水平的半胱氨酸使大肠杆菌对抗生素的耐药性增强,RNA-Seq的结果证明了胱氨酸内流对Fur、CysB和SOS的调控作用。LC-MS对外流硫醇的分析显示,细胞会快速将过量内流的半胱氨酸泵出胞外。在抗生素一定浓度范围内,半胱氨酸外排泵AlaE表现出良好的细胞保护作用。【结论】大肠杆菌对不同作用机理抗生素硫酸庆大霉素、氨苄青霉素和诺氟沙星的耐药性均受内源半胱氨酸水平的影响。本文通过研究半胱氨酸调控活性氧代谢对大肠杆菌耐药性的影响,为探讨细菌耐药性机制提供新的理论依据。     

Global and local depletion of ternary complex limits translational elongation

The translation of genetic information according to the sequence of the mRNA template occurs with high accuracy and fidelity. Critical events in each single step of translation are selection of transfer RNA (tRNA), codon reading and tRNA-regeneration for a new cycle. We developed a model that accurately describes the dynamics of single elongation steps, thus providing a systematic insight into the sensitivity of the mRNA translation rate to dynamic environmental conditions. Alterations in the concentration of the aminoacylated tRNA can transiently stall the ribosomes during translation which results, as suggested by the model, in two outcomes: either stress-induced change in the tRNA availability triggers the premature termination of the translation and ribosomal dissociation, or extensive demand for one tRNA species results in a competition between frameshift to an aberrant open-reading frame and ribosomal drop-off. Using the bacterial Escherichia coli system, we experimentally draw parallels between these two possible mechanisms.     

细菌对氨基糖苷类抗生素产生抗性的机理及其控制策略

氨基糖苷类抗生素在治疗感染性疾病尤其是革兰氏阴性菌引起的严重感染方面起着重要作用 ,但是耐药菌株的出现较大地限制了此类抗生素的发展 ,因此 ,如何控制耐药性已经成为一项迫切需要解决的任务。细菌对氨基糖苷类抗生素产生抗性的机制很多 ,目前普遍接受的主要有三种 :1. 通过减少对氨基糖苷类抗生素的摄取或减少药物在体内的累积而产生抗性。 2. 通过改变核糖体结合位点而产生抗性。 3. 通过表达氨基糖苷类抗生素修饰酶而产生抗性。目前细菌耐药性的控制主要集中在对原有氨基糖苷类抗生素进行改造或合成新的抗生素 ,开发氨基糖苷类抗生素修饰酶抑制剂。     

Structural basis for selectivity and toxicity of ribosomal antibiotics

Ribosomal antibiotics must discriminate between bacterial and eukaryotic ribosomes to various extents. Despite major differences in bacterial and eukaryotic ribosome structure, a single nucleotide or amino acid determines the selectivity of drugs affecting protein synthesis. Analysis of resistance mutations in bacteria allows the prediction of whether cytoplasmic or mitochondrial ribosomes in eukaryotic cells will be sensitive to the drug. This has important implications for drug specificity and toxicity. Together with recent data on the structure of ribosomal subunits these data provide the basis for development of new ribosomal antibiotics by rationale drug design.     

Tigecycline is modified by the flavin-dependent monooxygenase TetX

The clinical use of tetracycline antibiotics has decreased due to the emergence of efflux and ribosomal protection-based resistance mechanisms. Currently in phase III clinical trials, the glycylcycline derivative tigecycline (GAR-936) containing a 9-tert-butylglycylamido group is part of a new generation of tetracycline antibiotics developed during the 1990s. Tigecycline displays a broad spectrum of antibacterial activity and circumvents the efflux and ribosomal protection resistance mechanisms. The TetX protein is a flavin-dependent monooxygenase that modifies first and second generation tetracyclines and requires NADPH, Mg(2+), and O(2) for activity. We report that tigecycline is a substrate for TetX and that bacterial strains containing the tet(X) gene are resistant to tigecycline. The resistance is due to the modification of tigecycline by TetX to form 11a-hydroxytigecycline, which we have shown has a weakened ability to inhibit protein translation compared with tigecycline. We have explored the basis of this decreased ability to block translation and found that hydroxylation occurs in the region of the molecule important for coordinating magnesium. 11a-Hydroxytigecycline forms a weaker complex with magnesium than tigecycline; the crystal structure of tetracycline in complex with the ribosome has shown that magnesium coordination is critical for binding tetracycline. Although tet(X) has not been isolated from any clinically resistant strains, our report demonstrates the first enzymatic resistance mechanism to tigecycline and provides an alert for the surveillance of resistant strains that may contain tet(X).     

Bacterial multidrug efflux pumps: Mechanisms,physiology and pharmacological exploitations

Multidrug resistance (MDR) refers to the capability of bacterial pathogens to withstand lethal doses of structurally diverse drugs which are capable of eradicating non-resistant strains. MDR has been identified as a major threat to the public health of human being by the World Health Organization (WHO). Among the four general mechanisms that cause antibiotic resistance including target alteration, drug inactivation, decreased permeability and increased efflux, drug extrusion by the multidrug efflux pumps serves as an important mechanism of MDR. Efflux pumps not only can expel a broad range of antibiotics owing to their poly-substrate specificity, but also drive the acquisition of additional resistance mechanisms by lowering intracellular antibiotic concentration and promoting mutation accumulation. Over-expression of multidrug efflux pumps have been increasingly found to be associated with clinically relevant drug resistance. On the other hand, accumulating evidence has suggested that efflux pumps also have physiological functions in bacteria and their expression is subject tight regulation in response to various of environmental and physiological signals. A comprehensive understanding of the mechanisms of drug extrusion, and regulation and physiological functions of efflux pumps is essential for the development of anti-resistance interventions. In this review, we summarize the development of these research areas in the recent decades and present the pharmacological exploitation of efflux pump inhibitors as a promising anti-drug resistance intervention.     

结核分枝杆菌耐氟喹诺酮类药物的分子机制研究进展

结核病是由结核分枝杆菌(Mycobacterium tuberculosis)通过空气传播引起人类感染的慢性传染病,耐药结核分枝杆菌的流行是目前结核病防治的世界难题。氟喹诺酮类药物是人工合成药物,应用于耐药结核的临床治疗中,在治疗中起着核心的作用。但近年来,氟喹诺酮类药物的抗性菌株不断出现,愈发增加了结核病治疗的困难与治疗失败风险。在临床中氟喹诺酮药物的靶点比较清楚,是结核分枝杆菌的DNA旋转酶。目前发现结核分枝杆菌耐氟喹诺酮类药物的机制主要包括药物靶点DNA旋转酶的关键氨基酸改变、药物外排泵系统、细菌细胞壁厚度的增加以及喹诺酮抗性蛋白MfpA介导的DNA旋转酶活性调控。其中在氟喹诺酮靶标DNA旋转酶功能活性改变的耐药机制方面,编码DNA旋转酶基因突变一直是研究的热点,但近年来发现DNA旋转酶的调控蛋白MfpA以及DNA旋转酶的修饰在细菌耐药性中起着重要的作用,相关机制还亟待发现。本文综述了当前结核分枝杆菌耐氟喹诺酮类药物的作用机制,旨在为研发精准诊断技术和药物发掘提供科学理论基础和参考。     

Genetic reconstruction of protozoan rRNA decoding sites provides a rationale for paromomycin activity against Leishmania and Trypanosoma

Aminoglycoside antibiotics target the ribosomal decoding A-site and are active against a broad spectrum of bacteria. These compounds bind to a highly conserved stem-loop-stem structure in helix 44 of bacterial 16S rRNA. One particular aminoglycoside, paromomycin, also shows potent antiprotozoal activity and is used for the treatment of parasitic infections, e.g. by Leishmania spp. The precise drug target is, however, unclear; in particular whether aminoglycoside antibiotics target the cytosolic and/or the mitochondrial protozoan ribosome. To establish an experimental model for the study of protozoan decoding-site function, we constructed bacterial chimeric ribosomes where the central part of bacterial 16S rRNA helix 44 has been replaced by the corresponding Leishmania and Trypanosoma rRNA sequences. Relating the results from in-vitro ribosomal assays to that of in-vivo aminoglycoside activity against Trypanosoma brucei, as assessed in cell cultures and in a mouse model of infection, we conclude that aminoglycosides affect cytosolic translation while the mitochondrial ribosome of trypanosomes is not a target for aminoglycoside antibiotics.     

Comparative proteomics to evaluate multi drug resistance in Escherichia coli

Drug resistance in food-borne bacterial pathogens is an almost inevitable consequence of the use of antimicrobial drugs, used either therapeutically or to avoid infections in food-producing animals. In the past decades, the spread and inappropriate use of antibiotics have caused a considerable increase of antibiotics to which bacteria have developed resistance and, moreover, bacteria are becoming resistant to more than one antibiotic simultaneously. Understanding mechanisms at the molecular level is extremely important to control multi-resistant strains and to develop new therapeutic strategies. In the present study, comparative proteomics was applied to characterize membrane and cytosolic proteome in order to investigate the regulation of protein expression in multi-resistance E. coli isolated from young never vaccinated water buffalo. Results highlighted differentially expressed proteins under multi drug resistance conditions giving new insights about mechanisms involved in resistance, as quorum sensing mechanisms, and suggesting possible novel bacterial targets to develop alternative antibiotic drugs.